FTC approves final order requiring Grifols to divest assets as condition of acquiring Biotest
MLex Summary: The US Federal Trade Commission has approved a final order that settles charges that Grifols’s acquisition of Biotest US Corporation is anticompetitive and violates federal antitrust law. The settlement requires Grifols...To view the full article, register now.
Already a subscriber? Click here to view full article